Search research articles
Contact Us
Filters
Showing results (221-230 of 265) with videos related to
Page
of 27
Sort By:
Clinical and Translational Radiation Oncology
|
January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
Alexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Advanced Biology
|
March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
Mojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
NPJ Precision Oncology
|
February 13, 2023
Survival improvement for patients with metastatic colorectal cancer over twenty years
Fadl A Zeineddine, Mohammad A Zeineddine, Abdelrahman Yousef, et al.
Cancer Research Communications
|
December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination
Kristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Nature Communications
|
October 6, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Ming Lei, Michael J Overman, Jin Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2021
Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
Jonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer
Donastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 265) with videos related to
Sort By:
Page
of 27
Clinical and Translational Radiation Oncology
|
January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
Alexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Advanced Biology
|
March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
Mojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
NPJ Precision Oncology
|
February 13, 2023
Survival improvement for patients with metastatic colorectal cancer over twenty years
Fadl A Zeineddine, Mohammad A Zeineddine, Abdelrahman Yousef, et al.
Cancer Research Communications
|
December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination
Kristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Nature Communications
|
October 6, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Ming Lei, Michael J Overman, Jin Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2021
Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
Jonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer
Donastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Page
of 27